Study of GSK1363089 in Metastatic Gastric Cancer
Trial ID or NCT#
NCT00725712
Status
NOT RECRUITING
Purpose
This clinical study is being conducted at multiple sites to determine the best confirmed response rate, safety, and tolerability of GSK1363089 treatment in metastatic gastric carcinoma.
Official Title
A Phase 2 Study of GSK1363089 (XL880) Administered Orally to Subjects With Metastatic Gastric Cancer
Investigator(s)
James M Ford
Medical oncologist,
Gastrointestinal specialist,
Cancer geneticist
Professor of Medicine (Oncology) of Genetics and, by courtesy, of Pediatrics
Contact us to find out if this trial is right for you.
Contact
Heidi Kaiser
6507240079
View on ClinicalTrials.gov
